Deepull
deepull.com
Actively hiring
Higher Education
Cinema
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$54M
1 round on record
Latest round
$54M
Series C · Apr 2025 · 17 mo ago
Backers
1
Asabys Partners
The money's age
Due for its next round
17 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series C | Apr 2025 | $54M | — | menafn.com |
Registers and programsofficial lists and records that name the company
| Legal entity | DEEPULL DIAGNOSTICS S.L. | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Asabys Partners Similar startupsby what they do, their industry and backers
Lunaphore Technologies is a spatial biology company based in Tolochenaz near Lausanne, Switzerland, that builds instruments and reagents…
Restoring Blood Flow, Renewing Life. Creating new vascular pathways through targeted cell therapy and biomaterial engineering.
Direct Income to Communities. Protected Ecosystems. At Scale.
Kino is a collaborative video editor. Share your timeline as a URL, search every frame by meaning, and edit with AI.
Building the next great. Mobile tv shows are stories that are designed to be watched and talked about on your phone. We build technology…
L is B （エルイズビー）は、ビジネスチャット「direct」や、現場の写真管理システム「タグショット/タグアルバム」、現場のノウハウを動画で共有する「ナレッジ動画」など多彩なソリューションを提供し、お客様の課題解決に向け、現場の業務改善・DX化を支援します。.
News
deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection
deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection Round co-led by Columbus Venture Partners, Panakès Partners and Mérieux Equity Partners Barcelona, Spain - 29
Read more
Report
Deepull Secures Oversubscribed €50 Million Series C Financing To Advance Ullcore Diagnostic System For Direct-From-Blood Rapid Pathogen Detection
Read more
Report
deepull receives FDA Breakthrough Device Designation for its UllCORE Bloodstream Infection Test
media480497
Read more
Report
deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024
deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024 UllCORE is designed to transform life-saving clinical decision making for sepsis patients Barcelona, Spain - 25 April 2024 - deepull, a medical
Read more
Report
deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024
Read more
Report
Surviving Sepsis Campaign Guidelines 2021
1) https:www.sccm.orgClinical-ResourcesGuidelinesGuidelinesSurviving-Sepsis-Guidelines-2021
Read more
Report
Financials
Total raised
$54M
Latest round
Series C
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series C | 2025 | $54M | Details |